Creating a research center for HIV-related cancers in the US and East Africa
Administrative Core
This study is working to create a center that helps people in the U.S. and East Africa better prevent, find early, and treat cancers linked to HIV, so that patients can get better care and support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10866359 on NIH RePORTER |
What this research studies
This project aims to establish the United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC), focusing on the prevention, early detection, and efficient care for cancers related to HIV. The research will involve collaboration between US institutions and those in low- and middle-income countries (LMICs) to enhance biomedical research capacity and career development opportunities. The center will facilitate communication among researchers, engage with local stakeholders, and oversee financial aspects of the research initiatives. By fostering a multi-country network, the project seeks to improve outcomes for patients affected by HIV-associated malignancies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are at risk for or diagnosed with HIV-associated cancers.
Not a fit: Patients who do not have HIV or are not at risk for HIV-related malignancies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for HIV-related cancers, ultimately enhancing patient care.
How similar studies have performed: Previous research has shown success in collaborative approaches to HIV-related health issues, indicating potential for positive outcomes in this novel initiative.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.